Cerluten
- Category
- Bioregulators
- Administration routes
- Oral
- Regulatory status
- Not FDA-approved
What it is
A bioregulator peptide complex from bovine brain tissue, marketed to support cognition and slow age-related brain decline via effects on neuron gene expression. Human evidence is minimal, cognitive and metabolic benefit claims are speculative, and the neuroprotective signal is low-confidence, mostly animal-derived. Most supply is unregulated research-grade product of uncertain purity, plus an unresolved prion concern given its origin. Not FDA-approved.
Read Full recordStudied uses & evidence
Studied uses(3)
Support for cognitive function in elderly patients
SpeculativeA developer clinical report exists; independent confirmation is lacking.
Neuroprotective activity in age-related CNS decline
LowExtensive animal data support the peptide class, but no direct testing of Cerluten itself.
Normalization of brain cell metabolism
SpeculativeMechanism-based only; cited studies used a different peptide in cell cultures, not Cerluten in humans.
Evidence limits
- Evidence Level
- Very Limited Evidence
Clinical evidence for Cerluten consists primarily of small open-label studies conducted at the St. Petersburg Institute of Bioregulation and Gerontology. These studies report improvements in cognitive function, memory, and neurological symptoms in elderly patients, but lack randomization, blinding, and placebo controls. No independent Western clinical trials have been conducted. The neuroprotective peptide review (PMID 24738258) provides context on the broader class but does not constitute direct evidence for Cerluten specifically.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
General cautions
Pregnancy or breastfeeding
AbsoluteNo human reproductive safety data exists for this peptide. Effects on fetal development are unknown.
Children under 18
AbsoluteNo pediatric safety data. Not recommended for use in minors.
Known hypersensitivity
AbsoluteDiscontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).
Risk summary(3)
Risks = level of concern: High · Moderate · Low · Theoretical
Allergic reaction to animal-derived peptides
LowPrion disease concerns (bovine brain origin)
TheoreticalLack of independent quality control
High
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.